Okay, let's tackle this question about Marfan's syndrome. The user wants me to explain the correct answer and why the others are wrong. First, I need to recall what Marfan's syndrome is. It's a genetic disorder affecting the connective tissue. The core concept here is the gene involved.

Marfan's is caused by a mutation in the FBN1 gene, which codes for fibrillin-1. That's a key protein in the extracellular matrix. The mutation leads to defective microfibril formation, which affects various tissues like the aorta, eyes, and skeleton. So the correct answer should be FBN1.

Now, the options aren't listed, but common wrong options might include other genes like COL1A1 (Osteogenesis Imperfecta), COL4A5 (Alport's syndrome), or even TGFBR2 (Loeys-Dietz syndrome). Each of these is associated with different connective tissue disorders. I need to explain why each of these is incorrect. For example, COL1A1 is for collagen type I, which is different from fibrillin-1. COL4A5 is for collagen type IV, involved in basement membranes. TGFBR2 is part of the TGF-beta pathway, which is related but distinct from fibrillin-1's role.

Clinical pearls: Remember that Marfan's is autosomal dominant. The main gene is FBN1. The aortic dissection risk is high, so monitoring is crucial. Also, the Beighton criteria for joint hypermobility aren't specific here.

Putting it all together, the explanation should be concise, cover each section as per the user's instructions, and stay within the character limit. Make sure to use bold for section headers and key terms, and structure each part clearly without markdown beyond what's specified.

**Core Concept**
Marfan's syndrome is an autosomal dominant disorder caused by mutations in the *FBN1* gene, which encodes fibrillin-1. Fibrillin-1 is a structural component of extracellular microfibrils critical for elastic tissue integrity in the aorta, eyes, and skeleton. Defective fibrillin-1 disrupts TGF-β signaling, leading to connective tissue fragility.

**Why the Correct Answer is Right**
The *FBN1* gene mutation is the definitive genetic cause of Marfan's syndrome. Fibrillin-1 microfibrils form the scaffold for elastin in connective tissues. Mutations reduce functional fibrillin-1, causing weakened aortic walls (risking dissection), lens dislocation, and skeletal abnormalities. This ties directly to the clinical triad of aortic root dilation, arachnodactyly, and ectopia lentis.

**Why Each Wrong Option is Incorrect**
**Option A:** *COL1A1* (collagen type I alpha-1) mutations cause osteogenesis imperfecta, not Marfan's.
**Option B:** *COL4A5* (collagen type IV alpha-5) mutations are linked to Alport syndrome (renal/auditory/ocular issues).
**Option C:** *TGFBR2* (TGF-beta receptor 2) mutations are associated with Loeys-Dietz syndrome, which shares some features with Marfan's but has distinct genetic and clinical markers.

**Clinical

✓ Correct Answer: C. Fibrillin I